Company Overview
Company Name
Alzheon
Address
111 Speen St #306, Framingham, MA, 01701, United States
Website
alzheon.comPhone
(508) 861-7709Approx. Annual Revenue
$6.3M
About Alzheon
Alzheon is a biopharmaceutical company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders. The company is headquartered in Framingham, Massachusetts, and its lead candidate, ALZ-801, is currently in phase 3 clinical trials as an oral anti-amyloid treatment with the potential to slow or stop the progression of Alzheimer's disease.